Crohn & Colitis Centre, Department of Gastroenterology and Hepatology, Rijnstate Hospital, Arnhem, The Netherlands.
Center for Marketing & Supply Chain Management, Nyenrode Business University, Breukelen, The Netherlands.
J Crohns Colitis. 2021 Nov 8;15(11):1837-1845. doi: 10.1093/ecco-jcc/jjab082.
Segmentation of patients based on psychological determinants of subjective health may provide new ways to personalized care. The cross-disease segmentation model developed by Bloem & Stalpers discriminates patients based on disease acceptance and perceived control. We aimed to validate the segmentation model, compare segments and evaluate whether segments independently correlate with quality of life in inflammatory bowel disease [IBD].
A cross-sectional study of adult IBD patients was performed with questionnaires on quality of life [32-item inflammatory bowel disease questionnaire], acceptance and perceived control [six items with 7-point Likert scale]. Four segments were formed [cut-off > 5]: [I] high acceptance, high control; [II] high acceptance, low control [III]; low acceptance, high control and; [IV] low acceptance, low control.
We included 686 patients. The acceptance and perceived control scales were unidimensionally structured and internally consistent. Segments differed significantly in age, smoking behaviour, diagnosis, disease duration, extra-intestinal manifestations, IBD medication, clinical disease activity and quality of life. High acceptance (standardized beta coefficient [ß] 0.25, p < 0.001), high perceived control [ß 0.12, p < 0.001] or both [ß 0.53, p < 0.001], were associated with a significantly better health-related quality of life compared with low acceptance and low perceived control. Sociodemographic and clinical factors explained 25% of the variance in quality of life. The explained variance significantly increased to 45% when the patients' segment was added to the model [ΔR2 20%, p < 0.001].
The segmentation model based on disease acceptance and perceived control is valid in IBD patients and discriminates different segments that correlate independently with quality of life. This may open new strategies for patient care.
基于主观健康的心理决定因素对患者进行细分可能为个性化护理提供新途径。Bloem 和 Stalpers 开发的跨疾病细分模型基于疾病接受度和感知控制对患者进行区分。我们旨在验证该细分模型,比较细分并评估细分是否独立与炎症性肠病(IBD)患者的生活质量相关。
采用问卷调查的方式对成年 IBD 患者进行横断面研究,调查内容包括生活质量(32 项炎症性肠病问卷)、接受度和感知控制(6 项 7 点 Likert 量表)。形成了 4 个细分[临界值> 5]:[I]高接受度、高控制力;[II]高接受度、低控制力[III];低接受度、高控制力和;[IV]低接受度、低控制力。
我们共纳入 686 例患者。接受度和感知控制量表具有单一维度结构且内部一致性良好。各细分在年龄、吸烟行为、诊断、疾病病程、肠外表现、IBD 药物、临床疾病活动度和生活质量方面存在显著差异。与低接受度和低感知控制相比,高接受度(标准化β系数[β]0.25,p < 0.001)、高感知控制[β 0.12,p < 0.001]或两者兼而有之[β 0.53,p < 0.001]与健康相关生活质量显著相关。社会人口统计学和临床因素解释了生活质量变异性的 25%。当将患者细分添加到模型中时,解释的变异性显著增加至 45%(ΔR2 20%,p < 0.001)。
基于疾病接受度和感知控制的细分模型在 IBD 患者中是有效的,并且可以区分与生活质量独立相关的不同细分。这可能为患者护理开辟新策略。